Rain Therapeutics
Income Statement
Last updated:
Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. over the previous period. Total operating expenses were $77,136,000.
Profit Margin
| 2019 | 0 | -10.68M | |
|---|---|---|---|
| 2020 | 0 | -19.19M | |
| 2021 | 0 | -51.39M | |
| 2022 | 0 | -75.72M |
RAIN Income Statement (2019 – 2022)
| 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|
Revenue | ||||
Revenue | 0 | 0 | 0 | 0 |
Cost of revenue | 0 | 0 | 0 | 0 |
Gross profit | 0 | 0 | 0 | 0 |
Operating exp. | ||||
Research and development | 61.4M | 40.77M | 15.36M | 7.29M |
Selling and marketing | 0 | 0 | 0 | 0 |
Total operating expenses | 77.13M | 51.51M | 18.95M | 10.82M |
Operating income | -77.13M | -51.51M | -18.95M | -10.82M |
Other income (expenses), net | 1.41M | 120K | -2.12M | -74K |
Income before tax | -75.72M | -51.39M | -21.08M | -10.90M |
Income tax expense | 3K | 2K | -1.88M | -219K |
Net income | -75.72M | -51.39M | -19.19M | -10.68M |
Earnings per share | ||||
Basic EPS | -2.71 | -2.65 | -1.8 | -1 |
Diluted EPS | -2.71 | -2.65 | -1.8 | -1 |
| Data source | Data source |